Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Ltd. ( (AU:OSX) ) has provided an announcement.
Osteopore Limited has secured market approval in Switzerland for its 3D-printed biomimetic and bioresorbable implants under the EU Medical Device Regulation. This approval, following a successful transition to the MDR and a partnership with Zimmer Biomet, enables Osteopore to strengthen its market presence in Switzerland and across Europe, providing a complete suite of craniofacial products. The approval is expected to enhance Osteopore’s operations and industry positioning, particularly in the European cranial implant market, which is projected to grow significantly.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean company specializing in regenerative medicine. It is a global leader in 3D-printed biomimetic and bioresorbable implants, focusing on the development of innovative medical solutions for neurosurgery and orthopedic surgery.
Average Trading Volume: 1,450,391
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$1.83M
See more data about OSX stock on TipRanks’ Stock Analysis page.